Insider Stock Trading History of Sonsini Peter W.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sonsini Peter W. since year 2005. The trader's CIK number is 1559807. At the time of this reporting, Sonsini Peter W. is the 10% Owner of Aveo Pharmaceuticals Inc . (stock ticker symbol AVEO). See this page for all insider trading activities at Aveo Pharmaceuticals Inc .

Note that in the past Sonsini Peter W. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sonsini Peter W. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-11 AVEO Aveo Pharmaceuticals Inc Buy 61,200 1.98 121,114
2018-12-07 AVEO Aveo Pharmaceuticals Inc Buy 117,100 1.98 232,326
2018-12-10 AVEO Aveo Pharmaceuticals Inc Buy 26,000 1.98 51,584
2018-12-06 AVEO Aveo Pharmaceuticals Inc Buy 27,300 1.99 54,408
2018-11-30 AVEO Aveo Pharmaceuticals Inc Buy 71,900 1.98 142,074
2018-11-28 AVEO Aveo Pharmaceuticals Inc Buy 24,500 1.99 48,828
2018-11-20 AVEO Aveo Pharmaceuticals Inc Buy 170,000 1.98 336,090
2018-11-15 AVEO Aveo Pharmaceuticals Inc Buy 340,000 1.86 632,060
2018-11-16 AVEO Aveo Pharmaceuticals Inc Buy 350,000 1.85 649,250
2018-11-19 AVEO Aveo Pharmaceuticals Inc Buy 510,000 1.88 956,760
2018-09-07 ADAP Adaptimmune Therapeutics Plc Buy 15,000,000 1.67 25,005,000
2018-08-21 AVEO Aveo Pharmaceuticals Inc Buy 663,716 2.26 1,499,998
2018-07-18 AVEO Aveo Pharmaceuticals Inc Buy 200,000 1.95 390,600
2018-07-19 AVEO Aveo Pharmaceuticals Inc Buy 50,600 2.00 101,149
2018-06-27 AVEO Aveo Pharmaceuticals Inc Buy 5,295 2.15 11,384
2018-06-28 AVEO Aveo Pharmaceuticals Inc Buy 187,130 2.10 392,785
2018-05-30 AVEO Aveo Pharmaceuticals Inc Buy 275 2.15 591
2018-05-21 AVEO Aveo Pharmaceuticals Inc Buy 32,200 2.15 69,069
2018-05-17 AVEO Aveo Pharmaceuticals Inc Buy 184,179 2.12 391,380
2018-05-18 AVEO Aveo Pharmaceuticals Inc Buy 20,100 2.14 42,933
2018-05-08 AVEO Aveo Pharmaceuticals Inc Buy 70,873 2.13 151,242
2018-04-23 SURF Surface Oncology, Inc. Buy 133,333 15.00 1,999,995
2018-04-06 AVEO Aveo Pharmaceuticals Inc Buy 685,676 2.24 1,537,285
2018-04-09 AVEO Aveo Pharmaceuticals Inc Buy 32,100 2.43 78,099
2018-04-10 AVEO Aveo Pharmaceuticals Inc Buy 203,200 2.46 500,075
2018-03-26 ADAP Adaptimmune Therapeutics Plc Buy 571,164 1.90 1,087,496
2018-03-27 ADAP Adaptimmune Therapeutics Plc Buy 6,000,000 1.92 11,502,000
2018-03-21 ADAP Adaptimmune Therapeutics Plc Buy 104,844 1.81 189,872
2018-03-22 ADAP Adaptimmune Therapeutics Plc Buy 869,574 1.90 1,655,668
2018-03-23 ADAP Adaptimmune Therapeutics Plc Buy 294,090 1.95 572,299
2018-02-26 ABIO Arca Biopharma, Inc. Sale 1,460,209 .50 731,564
2017-11-27 APPN Appian Corp Sale 569,620 19.49 11,101,893
2017-11-20 APPN Appian Corp Sale 2,820,516 19.49 54,971,856
2017-07-03 MRSN Mersana Therapeutics, Inc. Buy 1,000,000 15.00 15,000,000
2017-03-28 AVEO Aveo Pharmaceuticals Inc Buy 6,000,000 .50 3,000,000
2017-03-27 ADAP Adaptimmune Therapeutics Plc Buy 12,870,000 .70 9,009,000
2016-12-19 AKAO Achaogen, Inc. Buy 500,000 13.50 6,750,000
2016-12-19 AKAO Achaogen, Inc. Buy 500,000 13.50 6,750,000
2016-11-29 TCON Tracon Pharmaceuticals, Inc. Buy 869,565 5.75 4,999,998
2016-07-29 ILIU Interleukin Genetics Inc Buy 20,120,724 .10 1,991,951
2016-07-18 ARDX Ardelyx, Inc. Buy 1,527,301 8.73 13,333,337
2016-01-13 ARDX Ardelyx, Inc. Buy 1,000,000 10.00 10,000,000
2015-10-06 MIRN Synlogic, Inc. Buy 857,142 7.00 5,999,994
2015-02-04 TCON Tracon Pharmaceuticals, Inc. Buy 500,000 10.00 5,000,000
2014-12-23 ILIU Interleukin Genetics Inc Buy 19,868,965 .10 1,986,896
2014-08-06 LOXO Loxo Oncology, Inc. Buy 230,769 13.00 2,999,997

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sonsini Peter W. (10% Owner of Aveo Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.